Labopharm Inc. (NASDAQ: DDSS) today announced the FDA has approved OLEPTRO Extended Release Tablets, a novel once-daily formulation of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE